News

January 29, 2013 – ApneaRx®, New Transition Oral Appliance to Treat Sleep Apnea, Now Reimbursed Under HCPCS Code E0485

Laguna Hills, CA (PRWEB) January 29, 2013 – LAGUNA HILLS, Calif., Jan. 29, 2013 /PRNewswire/ – A new class of transition oral appliances has recently hit the market that will help qualify and cost effectively “transition” sleep apnea patients to custom oral appliance therapy. Apnea Sciences is leading the way with ApneaRx®, a Best in Class patented design that is more advanced than traditional “transition” oral appliances. It can be fitted and adjusted by trained sleep care providers – not just dentists. It is the only Boil and Bite oral appliance that can be adjusted in 1 mm increments to insure an optimal custom fit, without the use of screws, plastic straps, rubber bands, or other accessories.

ApneaRx® , a prescription device, is now recognized by Medicare to be highly effective and is now being reimbursed under HCPCS Code E0485 – prefabricated oral appliance. To qualify – patients must be diagnosed with mild to moderate sleep apnea, or be CPAP intolerant. Major health insurance companies that also reimburse are: Aetna, Anthem, BCBS, Cigna, United Healthcare and others. Since all insurance plan benefits vary and change over time, the patient’s insurance provider should be contacted to confirm its specific coverage policies. Patrick Maley, COO for Apnea Sciences’ Clinical Division, said, “The fact that both Medicare and private insurers recognize the value of ApneaRx® and are willing to reimburse for it is very positive news for our business.”

Dr. Walcott, A Board Certified Sleep Specialist from San Diego said, “CPAP intolerant patients will welcome this news as many have been waiting to see if an oral appliance is an acceptable alternative to their CPAP machines.” The American Academy of Sleep Medicine has long supported oral appliance interventional therapy for mild to moderate sleep apnea. The introduction of ApneaRx® will help these patients determine the right therapy for their care.

ApneaRx® was developed and is manufactured by Apnea Sciences. Other products are in development to address the large sleep disorder market.

July 22, 2012 – Apnea Sciences Accelerates Patient Access to a New Sleep Apnea Treatment ApneaRx represents a new more affordable therapy for sleep apnea patients.

Laguna Hills, CA (PRWEB) July 22, 2012 – ApneaRx®, Apnea Sciences’ new micro-adjustable boil and bite sleep apnea appliance, was just introduced last month. ApneaRx, a prescription device, provides an affordable way to help sleep care practitioners determine who will be good candidates for more expensive custom oral appliance therapy. According to Patrick Maley, COO, “the big challenge of introducing a novel product like ApneaRx is that initial patient demand typically outstrips the number of sleep care practitioners around the country prescribing, or offering the device.” Randy Clare, sleep business leader for CareFusion (distributor for ApneaRx) stated, “We have very quickly established national sales channels to make sure that sleep apnea patients can obtain ApneaRx while the sleep care provider market develops. Several well known apnea medical internet retailers have commenced selling ApneaRx. These internet retailers will help the patient to secure a prescription for ApneaRx from their treating sleep care practitioner. Essentially, these patients are acting as references by telling their friends and treating doctors about ApneaRx.”

Sleeprestfully.com was the first company to carry ApneaRx. Darin Stewart, General Manager remarked, “ApneaRx is the first oral appliance we have carried. Its easy-to-use adjustment capabilities make it a perfect complement for our CPAP users wanting a treatment alternative while traveling. I used it myself and became a believer.”

Roberta Baron, President of CPAP Supplies Plus commented, “Our customers want more treatment options for their sleep apnea. ApneaRx can not only be used as a predictor device for custom oral appliances, it can also be used in combination with CPAP therapy, or in lieu of chin straps for more comfort and/or reduced air pressure. ApneaRx’s capability of being fitted and adjusted by the practitioner, or patient makes it special.”

Easybreathe will launch ApneaRx in July. CEO, Nick Weiss, had this to say, “At Easybreathe, we’re 100% focused on making things easy for sleep apnea sufferers. ApneaRx is the only oral device that I’ve seen that meets our standards. By eliminating trips to the sleep specialist for fittings, and enabling 1 mm adjustments without screws, screw drivers or other devices, ApneaRx makes the overall experience easier for the patient. Easybreathe.com truly believes that making things easy for patients improves compliance and drives better outcomes.”

After many years of research and development, Apnea Sciences has used its patent pending technology to build a pipeline of devices to address the large snoring and sleep apnea markets. During the last few months it has secured FDA Approval for SnoreRx and ApneaRx to treat snoring and sleep apnea respectably.

 

June 20, 2012 – Apnea Sciences Introduces Major New Distributor For Its New Sleep Apnea Treatment

ApneaRx® is a prescription device and can only be provided to patients through a licensed sleep care practitioner. Sleep care providers can order ApneaRx from the CareFusion customer service department, 800-852-7458

Los Angeles, CA. (PRWEB) June 20, 2012 – The introduction of Apnea Sciences’ ApneaRx , a new patented micro-adjustable sleep apnea oral appliance, at the recent American Academy of Dental Sleep Medicine and Associated Professional Sleep Societies medical convention in Boston was a huge success according to Patrick Maley, COO. ApneaRx was specifically designed to help provide more cost effective sleep apnea therapy. It is the ONLY boil and bite sleep apnea appliance that can be easily fitted and titrated by the provider, or patient in 1mm increments without nuts, bolts, screw driver, or hardware of any kind. Time to fit ApneaRx is only about 10 minutes. According to sleep physician Frank Barch of Harrisonburg, Virginia, who has sleep apnea and uses ApneaRx, “I was not surprised by the amount of enthusiasm generated by ApneaRx at the sleep meetings. I have been looking for an oral appliance like ApneaRx for some time. Sleep MDs now have an easily titratable device that can be used to help predict the clinical utility of more expensive custom oral appliance therapy. It can also be offered to select sleep apnea patients that have no or limited health insurance as an affordable transition therapy. For appropriate patients who use PAP therapy, ApneaRx can offer a cost effective alternative when they are unable to use their PAP therapy, such as on camping trips.”

Apnea Sciences also proudly introduced CareFusion, a multi-billion dollar health care company that sells to sleep care providers, as its distributor for ApneaRx in the United States. Maley commented that “CareFusion has a strong track record of successfully introducing innovative and affordable products like ApneaRx to the sleep care community. CareFusion’s sleep industry connections and knowledge are particularly impressive.” Randy Clare, CareFusion’s sleep business leader commented, “The reception of ApneaRx at the sleep shows exceeded our expectations. Sleep practitioners quickly recognized ApneaRx’s potential as a diagnostic tool to help determine who may be responders, or non-responders for more expensive custom oral appliance therapy. In addition, they viewed ApneaRx as an affordable and easy-to-use “transition” treatment alternative for those sleep apnea patients without health insurance.”

ApneaRx is a prescription device and can only be provided to patients through a licensed sleep care practitioner. Sleep care providers can order ApneaRx from the CareFusion customer service department, 800-852-7458.

April 5, 2012 – FDA Approves ApneaRx® – A New Cure for Sleep Apnea

Patrick Maley, Chief Operating Officer of Apnea Sciences Corporation, announced that their breakthrough product ApneaRx was just approved by the FDA and is now available for the 20 million sleep apnea sufferers in America who think CPAP (continuous positive airway pressure mask pictured at right) is the only remedy for their disorder.

Laguna Hills, CA. (PRWEB) April 5, 2012 – Patrick Maley, Chief Operating Officer of Apnea Sciences Corporation, announced that their breakthrough product ApneaRx was just approved by the FDA and is now available for the 20 million sleep apnea sufferers in America who think CPAP (continuous positive airway pressure mask pictured at right) is the only remedy for their disorder.

Maley said, “Up until now there has not been an affordable “transition” oral appliance that has been good enough to help the medical practitioner decide whether an oral appliance, or CPAP therapy is best for their patients. Our research indicates that effective oral appliance therapy would be preferred by most patients.”
What makes ApneaRx unique is that it does this without any moving parts, screws, metal rods or plastic bands used by much more expensive devices, or metal hardware that could compromise the patient.

ApneaRx will help the practitioner decide which treatment is best for their patient – custom oral appliance or CPAP. Oral appliance users are more compliant and CPAP therapy is more effective. Both therapies are successful 50-60% of the time and cost thousands of dollars. ApneaRx can reduce the cost risks associated with these therapies. It can be adjusted just like the more expensive custom oral appliances at a fraction of the cost to help determine clinical efficacy of oral appliances. If the ApneaRx treatment is successful, a more customized oral appliance can be prescribed. If not, CPAP should be used. Continued usage of ApneaRx is also a good economic alternative.

Patrick Wolcott, MD, Medical Director of The Sleep Center of Southern California in Encinitas, California commented that “ApneaRx provides the sleep clinician with an inexpensive way to determine the best treatment for their patients. In my practice, oral appliance therapy often leads to better compliance and a happier patient.”

Ed Spiegel, DDS, a prominent dentist specializing in sleep medicine in Scottsdale Arizona who lectures nationally, stated that “ApneaRx is a great advancement and will help give patients more piece of mind when choosing custom oral appliance therapy to reduce their sleep apnea.”
Maley commented, “The reception for ApneaRx™ has been overwhelming. The need for a “transition” oral appliance to help determine the best and most cost effective sleep apnea treatment is being driven by industry trends to contain health costs.”

Dr. Wolcott believes ApneaRx will be well received by the sleep apnea medical community.

About Apnea Sciences
After many years of research and development, Apnea Sciences has used its patent pending technology to build a pipeline of devices to address the large snoring and sleep apnea markets. During the last few months it has secured FDA Approval for SnoreRx and ApneaRx to treat snoring and sleep apnea respectably.